Market Research Logo

Global Hemoglobinopathies Treatment Market 2019-2023

Global Hemoglobinopathies Treatment Market 2019-2023

About this market

Development of gene therapy to drive growth in the market. The advances of regenerative medicines in the clinical phases are expected to fuel growth of the global hemoglobinopathies treatment market. Technavio’s analysts have predicted that the hemoglobinopathies treatment market will register a CAGR of almost 11% by 2023.

Market Overview

Strong pipeline and expected approvals of late-stage molecule

The market is witnessing an acute lack of approved therapies, these late-stage pipeline molecules are expected to gain momentum during the forecast period, which will fuel the market growth.

Product recalls and tedious drug approval process

The strict regulations for providing the marketing approval for therapeutics that are being developed for the treatment of hemoglobinopathies is likely to pose a threat to the market.

For the detailed list of factors that will drive and challenge the growth of the hemoglobinopathies treatment market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Medunik USA and Novartis the competitive environment is quite intense. Factors such as the strong pipeline and expected approvals of late-stage molecule and the development of gene therapy, will provide considerable growth opportunities to hemoglobinopathies treatment manufactures. ApoPharma, Bristol-Myers Squibb, Emmaus Medical, Medunik USA, and Novartis are some of the major companies covered in this report.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Hemoglobinopathies Treatment Market 2019-2023

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the development of gene therapy.”

According to the report, one of the major drivers for this market is the strong pipeline and expected approvals of late-stage molecule.

Further, the report states that one of the major factors hindering the growth of this market is the product recalls and tedious drug approval process.

Companies Mentioned

ApoPharma
Bristol-Myers Squibb
Emmaus Medical
Medunik USA
Novartis

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global hematology drugs market
      • Table Segments of global hematology drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Sickle cell disease - Market size and forecast 2018-2023
      • Table Sickle cell disease - Market size and forecast 2018-2023 ($ millions)
      • Table Sickle cell disease - Year-over-year growth 2019-2023 (%)
    • Thalassemia - Market size and forecast 2018-2023
      • Table Thalassemia - Market size and forecast 2018-2023 ($ millions)
      • Table Thalassemia - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in APAC
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Therapeutics that have received the orphan drug designation from the US FDA recently
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ApoPharma
      • Table ApoPharma - Vendor overview
      • Table ApoPharma - Business segments
      • Table ApoPharma - Organizational developments
      • Table ApoPharma - Key offerings
      • Table ApoPharma - Key customers
    • Bristol-Myers Squibb
      • Table Bristol-Myers Squibb - Vendor overview
      • Table Bristol-Myers Squibb - Business segments
      • Table Bristol-Myers Squibb - Organizational developments
      • Table Bristol-Myers Squibb - Geographic focus
      • Table Bristol-Myers Squibb - Key offerings
      • Table Bristol-Myers Squibb - Key customers
    • Emmaus Medical
      • Table Emmaus Medical - Vendor overview
      • Table Emmaus Medical - Business segments
      • Table Emmaus Medical - Organizational developments
      • Table Emmaus Medical - Geographic focus
      • Table Emmaus Medical - Key offerings
      • Table Emmaus Medical - Key customers
    • Medunik USA
      • Table Medunik USA - Vendor overview
      • Table Medunik USA - Business segments
      • Table Medunik USA - Organizational developments
      • Table Medunik USA - Key offerings
      • Table Medunik USA - Key customers
    • Novartis
      • Table Novartis - Vendor overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
      • Table Novartis - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report